Divergent Pathogenic PR-DUB Complex Variants Converge Functionally Via PRC2 Displacement From Chromatin
Doyle, E. J.; Boyce, M.; Buggle, S.; Smith, T.; Dillon, E.; McElligott, A. M.; Orfali, N.; Coughlan, A. Y.; Pasini, D.; Conway, E.
Show abstract
The PR-DUB complex is responsible for erasing the repressive histone modification, H2AK119ub1. ASXL1-3 proteins are mutually exclusive catalytic partners of BAP1 in the PR-DUB complex. Somatic heterozygous ASXL1-3 variants are associated with cancer, including myeloid malignancies, while de novo germline variants cause neurodevelopmental disorders such as Bohring-Opitz syndrome. These pathogenic variants are almost exclusively nonsense and frameshift and have been proposed to act as gain-of-function. However, the precise catalytic impact and mechanism of variant ASXL1-3 remains elusive. Using an isogenic embryonic stem cell model we have discovered that ASXL1 BOS variants drive reductions - but not global ablations - in H2AK119ub1, consistent with gain-of-function. This catalytic change occurs through the production of a truncated ASXL1 protein with enhanced stability. Hyper-stabilised ASXL1 drives a stoichiometric shift in PR-DUB assembly away from ASXL2 complexes. The drop in H2AK119ub1 levels ultimately reduces PRC2 binding and H3K27me3 deposition. Surprisingly, this phenotype is shared across PR-DUB loss-of-function models and indeed is emerging as a common phenotype across genetically and mechanistically distinct Polycomb-related chromatinopathies.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- The SCP4-STK35/PDIK1L complex is a dual phospho-catalytic signaling dependency in acute myeloid leukemia 95%
- Fragile X Mental Retardation Protein regulates R-loop formation and prevents global chromosome fragility 94%
- Co-option of endogenous retroviruses through genetic escape from TRIM28 repression 94%
Similar papers in this journal
- The chromatin remodeller CHD4 regulates transcription factor binding to both prevent activation of silent enhancers and maintain active regulatory elements 95%
- ZMYM2 controls human transposable element transcription through distinct co-regulatory complexes 94%
- Integrated evaluation of telomerase activation and telomere maintenance across cancer cell lines 94%
Similar papers in this journal
Similar papers in this journal
- WAPL maintains dynamic cohesin to preserve lineage specific distal gene regulation 95%
- In vivo dissection of a clustered-CTCF domain boundary reveals developmental principles of regulatory insulation 95%
- High affinity enhancer-promoter interactions can bypass CTCF/cohesin-mediated insulation and contribute to phenotypic robustness 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.